Single-use Membrane Chromatography Systems Market Report 2026

The single-use membrane chromatography systems market size has grown rapidly in recent years. It will grow from $1.07 billion in 2025 to $1.21 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to growth in biologics manufacturing, expansion of vaccine production, rise in single use bioprocessing, need for faster purification cycles, increase in contract manufacturing.

The single-use membrane chromatography systems market size is expected to see rapid growth in the next few years. It will grow to $1.96 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to growth in gene and cell therapy, expansion of modular bioprocess plants, rising demand for flexible purification, adoption in viral vector production, scaling of continuous bioprocessing. Major trends in the forecast period include disposable high flow membrane modules, rapid downstream purification platforms, pre packed single use capsules, continuous membrane processing systems, low buffer consumption designs.

The rapid growth of biopharmaceutical production is expected to strengthen the expansion of the single-use membrane chromatography systems market going forward. The growth of biopharmaceutical production is driven by increasing global demand for biologic therapies, including monoclonal antibodies, vaccines, and advanced treatments. Single-use membrane chromatography systems support biopharmaceutical manufacturing by offering high-throughput, disposable purification solutions that allow faster and more efficient processing of biologics such as monoclonal antibodies. For example, in November 2025, according to a report published by the Ministry of Trade, Industry and Resources, a South Korea-based government ministry, Korea’s bioindustry production reached KRW 22.9 trillion, representing a 9.8% increase from the previous year. Therefore, the rapid growth of biopharmaceutical production is contributing to the growth of the single-use membrane chromatography systems market.

Key companies operating in the single-use membrane chromatography systems market are concentrating on technological advancements, such as ultra-fast single-use affinity chromatography, to achieve higher downstream processing efficiency, faster antibody capture, reduced purification cycle times, and improved scalability from research to commercial manufacturing. Ultra-fast single-use affinity chromatography refers to membrane-based, disposable chromatography systems that use high-flow affinity ligands to capture target biomolecules. For instance, in October 2024, Sartorius AG, a Germany-based company, launched Sartobind Rapid A Lab. Sartobind Rapid A Lab provides a plug-and-play, single-use Protein A membrane chromatography solution designed to accelerate antibody purification workflows. It enables ultra-fast antibody capture in under three minutes using a high-flow membrane matrix that delivers significantly higher lifetime yields than traditional resin columns. The unit operates without column packing, buffer degassing, or cleaning-in-place, reducing process complexity and setup time. It supports flexible operation with syringes, pumps, or liquid chromatography systems, eliminating the need for dedicated chromatography infrastructure.

In October 2024, Shimadzu Corporation, a Japan-based supplier of analytical instruments, chromatography systems, mass spectrometry solutions, and laboratory technologies, partnered with Sepragen Corporation. Through this collaboration, Shimadzu sought to expand its bioprocessing and downstream purification offerings while strengthening its regional market presence by delivering advanced single-use and process-scale chromatography systems to biopharmaceutical manufacturers. Sepragen Corporation is a US-based company providing chromatography solutions for biologics purification, including systems for monoclonal antibodies and other biopharmaceutical products.

Major companies operating in the single-use membrane chromatography systems market are Thermo Fisher Scientific Inc., 3M Company, Merck Millipore, Danaher Corporation, GE Healthcare, Asahi Kasei Corporation, Agilent Technologies Inc., Cytiva, Sartorius AG, Bio-Rad Laboratories Inc., Repligen Corporation, Phenomenex Inc., Cole-Parmer Instrument Company LLC, Membrane Solutions LLC, Graver Technologies LLC, Regis Technologies Inc., Purilogics Inc., BIA Separations d.o.o., Cobetter Filtration Equipment Co. Ltd., i3 Membrane Partnership Ltd.

Tariffs are influencing the single use membrane chromatography systems market by increasing the cost of imported membranes, chromatography hardware, and specialized filtration materials. Higher duties are raising equipment and consumable prices across anion, cation, and mixed mode membrane segments. Biopharmaceutical and contract manufacturing users that rely on imported purification modules are most affected. Regions dependent on cross border biotech equipment trade, especially in europe and asia pacific, face higher procurement costs. Suppliers are expanding regional manufacturing and localized assembly operations. Tariffs are also encouraging domestic production of membrane materials and cartridges. This supports stronger local bioprocess supply chains and faster delivery timelines.

The single-use membrane chromatography systems market research report is one of a series of new reports that provides single-use membrane chromatography systems market statistics, including single-use membrane chromatography systems industry global market size, regional shares, competitors with a single-use membrane chromatography systems market share, detailed single-use membrane chromatography systems market segments, market trends and opportunities, and any further data you may need to thrive in the single-use membrane chromatography systems industry. This single-use membrane chromatography systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Single-use membrane chromatography systems are disposable purification solutions applied in biopharmaceutical manufacturing to isolate and purify biomolecules including proteins, antibodies, and viral vectors. They utilize functionalized membrane materials instead of conventional resin columns, allowing high flow rates, faster processing, and lower buffer usage. They support efficient, adaptable, and contamination-free purification processes in bioproduction workflows.

The primary product types of single-use membrane chromatography systems include anion exchange membrane chromatography, cation exchange membrane chromatography, and mixed-mode membrane chromatography. Anion exchange membrane chromatography refers to systems that separate biomolecules based on their net negative charge, improving purification efficiency in bioprocessing workflows. These systems employ techniques such as ion exchange membrane chromatography, affinity membrane chromatography, hydrophobic interaction membrane chromatography, and mixed-mode membrane chromatography. They are applied across areas including biopharmaceuticals, clinical research, academic research, and other applications, and are utilized by end users including pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs), and other end users.

The single-use membrane chromatography systems market consists of sales of membrane chromatography capsules, membrane chromatography cartridges, membrane chromatography cassettes, single-use chromatography columns, disposable membrane modules, chromatography membrane filters, and single-use sample bags. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.